​Cayman Chemical, in collaboration with BMG LABTECH GmbH, has developed a novel assay kit to measure mitochondrial function under a dynamic range of oxygen concentrations. The Mito Stress Test (ACU Format) is designed to measure oxygen consumption rate (OCR) and extracellular acidification (ECA) simultaneously and in real time under tightly controlled atmospheric conditions using open-flow respirometry. The assay [...]

SANTA CLARA, Calif. -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has launched an e-commerce platform to support the commercialization of its Life Science products. The launch follows the recent expansion of [...]

The 11th WRIB on April 3-7, 2017 in Los Angeles/Universal City (Hilton LA/Universal City) will continue to be a forum where regulators and industry convene for working together in the field of bioanalysis, biomarkers, and immunogenicity to improve global health. Participating Regulators at the 11th WRIB will again include all Major and Influential Regulatory Agencies in North America, Europe, Latin America, [...]

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has signed a distributor agreement in India with Electrolab India Pvt. Ltd. John DiBella, vice president for marketing and sales of Simulations Plus, said: “The Indian pharmaceutical market [...]

BERGISCH GLADBACH – MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade.   Cell activation is a prerequisite for the successful genetic engineering of T cells. MACS GMP T Cell TransAct from Miltenyi Biotec – with its unique features – [...]

Menlo Park, CA – Personalis, Inc., a precision medicine company focused on genomics solutions for immuno-oncology, cancer, and genetic disease, today announced the order of ten Illumina NovaSeq 6000 systems to continue to scale its operations in 2017. The first two instruments have now been delivered. Personalis is partnering with leading biopharmaceutical companies to accelerate cancer [...]

Today Biognosys announces the release of a new version of SpectroDive™ - Biognosys’ software for targeted proteomics. SpectroDive™ 8.0 now supports library generation from DDA results and subsequent panel generation for data acquisition with Multiple or Parallel Reaction Monitoring (MRM and PRM) workflows. Targeted proteomics is a powerful mass spectrometry based technique for highly specific and sensitive multiplexed quantification of selected proteins [...]

Diploma PLC, the international group of businesses supplying specialised technical products and services, is pleased to announce the acquisition of 100% of Abacus ALS Pty Ltd ("Abacus").  Abacus is a long-established supplier of clinical diagnostics instrumentation and consumables to the Pathology and Life Sciences sectors. Abacus has particular strengths in Immunology and Biochemistry testing, supplying [...]

- Sizes range from 3-liter bench-top to 1000-liter manufacturing scale - Fully scalable system streamlines drug development and production DARMSTADT, Germany -- Merck, a leading science and technology company, today announced that BioInvent International AB, a Swedish company which develops novel immuno-regulatory antibodies to treat cancer, is upgrading and expanding its drug manufacturing facility with a full line of [...]

SAN DIEGO and CAMBRIDGE, ENGLAND –– Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases, which otherwise can take months or years, while also reducing costs. [...]